Medical application of notoginsenoside R1

A technology of Panax notoginseng saponins and drugs, which is applied in the field of medical use of Panax notoginseng saponins R1, can solve the problems of poor blood sugar control, affecting wound healing, and reducing the ability to eliminate bacteria.

Active Publication Date: 2015-07-08
SHANGHAI UNIV OF T C M
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, the blood sugar control of diabetic patients is not good, and the body's ability to eliminate bacteria will be reduced
H...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical application of notoginsenoside R1
  • Medical application of notoginsenoside R1
  • Medical application of notoginsenoside R1

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0036] 1. Experimental materials

[0037] 1.1 Medicinal materials

[0038] Notoginsenoside R1 (CAS: 80418-24-2, molecular weight 933.13, HPLC purity ≥ 98%, Shanghai Yilin Biotechnology Co., Ltd.)

[0039] 1.2 Experimental animals

[0040] db / db female mice (12 weeks) weighing 50±5g were provided by the Experimental Animal Center of Shanghai University of Traditional Chinese Medicine, animal certificate number: SCXK (Beijing) 2011-0012. Placed in a conventional feeding environment, housed in separate cages, free to eat and drink.

[0041] 2. Experimental method

[0042] 2.1 Establishment of diabetes injury model

[0043] Using the modeling method in the literature (Nature Protocols, 2013, 8:302-309), after isoflurane anesthesia, the back skin was shaved, and the skin was disinfected routinely. A hole punch with a diameter of 6 mm was used to cut a circle on both sides of the back spine. Shaped incision, deep to the fascia. In order to prevent the wound from shrinking auto...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicine and pharmacology, in particular to medical application of notoginsenoside R1. Animal experiments show that notoginsenoside R1 can effectively promote healing of diabetic wounds and has significance for treatment of diabetic gangrene.

Description

technical field [0001] The invention relates to the field of medicine and health products, in particular to the medical use of a notoginseng saponin R1. Background technique [0002] Diabetes is a metabolic disease that seriously threatens human health, and has become the fourth leading cause of death after cardiovascular, tumor and AIDS. Statistics show that there are currently 285 million diabetic patients in the world, and it is predicted that by 2030, the number of diabetic patients in the world will reach 439 million, and the complications caused by diabetes have become the main cause of disability and death of patients. Among the many complications of diabetes, the impaired wound healing ability of diabetic patients is a typical complication of diabetes. If chronic injuries and ulcers occur in the feet, it may cause diabetic foot, and even lead to amputation in severe cases. Diabetes is the disease with the highest hospitalization rate, and it is reported that there i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/704A61P17/02A23L1/30A61K8/63A61Q11/00
Inventor 王峥涛张二云高波黄玲芳杨莉吴晓俊
Owner SHANGHAI UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap